THEMIS MEDICARE
Quarterly Results Analysis [Dec2023]
THEMIS MEDICARE Quarterly Results
Consolidated | Dec2023 UnAudited |
Sep2023 UnAudited |
Jun2023 UnAudited |
Mar2023 UnAudited |
Dec2022 UnAudited |
Sep2022 UnAudited |
Jun2022 UnAudited |
Mar2022 Audited |
---|---|---|---|---|---|---|---|---|
Revenues | ₹83 Cr | ₹105 Cr | ₹97 Cr | ₹80 Cr | ₹89 Cr | ₹91 Cr | ₹94 Cr | ₹80 Cr |
Expenses | ₹74 Cr | ₹92 Cr | ₹75 Cr | ₹70 Cr | ₹74 Cr | ₹70 Cr | ₹74 Cr | ₹65 Cr |
Operating Income | ₹8 Cr | ₹12 Cr | ₹22 Cr | ₹10 Cr | ₹15 Cr | ₹21 Cr | ₹20 Cr | ₹14 Cr |
Other Income | ₹1 Cr | ₹2 Cr | ₹1 Cr | ₹3 Cr | ₹6 Cr | ₹2 Cr | ₹1 Cr | ₹2 Cr |
Interest | ₹3 Cr | ₹2 Cr | ₹2 Cr | ₹3 Cr | ₹2 Cr | ₹2 Cr | ₹2 Cr | ₹2 Cr |
Depreciation | ₹3 Cr | ₹3 Cr | ₹3 Cr | ₹3 Cr | ₹3 Cr | ₹3 Cr | ₹2 Cr | ₹2 Cr |
Profit Before Tax | ₹3 Cr | ₹10 Cr | ₹17 Cr | ₹8 Cr | ₹16 Cr | ₹18 Cr | ₹16 Cr | ₹12 Cr |
Profit After Tax | ₹2 Cr | ₹7 Cr | ₹13 Cr | ₹6 Cr | ₹12 Cr | ₹14 Cr | ₹12 Cr | ₹8 Cr |
EPS | ₹8.01 | ₹1.23 | ₹1.98 | ₹0.91 | ₹14.47 | ₹1.93 | ₹1.89 | ₹1.08 |
Industry Peers & Returns | 1W | 1M | 1Y |
THEMIS MEDICARE | 4.3% | -1.4% | 43.1% |
SUN PHARMACEUTICAL INDUSTRIES | -2.3% | -6.5% | 55.3% |
CIPLA | 4.1% | -4.8% | 55.6% |
DR REDDYS LABORATORIES | 4% | 0.8% | 29.4% |
ZYDUS LIFESCIENCES | -1.2% | -5.2% | 83.9% |
DIVIS LABORATORIES | 7.8% | 17.4% | 20.3% |
MANKIND PHARMA | 1.3% | 7% | NA |
TORRENT PHARMACEUTICALS | 3.9% | 5.1% | 66.1% |
LUPIN | 0.6% | 0.5% | 127.2% |
THEMIS MEDICARE Quarterly Revenues
Revenues | |
---|---|
Q-o-Q | -21.25 % |
Y-o-Y | -7.06 % |
Quarters | Revenues | % Change | |
---|---|---|---|
Dec2023 | ₹83 Cr | -21.25 | |
Sep2023 | ₹105 Cr | 8.42 | |
Jun2023 | ₹97 Cr | 20.65 | |
Mar2023 | ₹80 Cr | -9.77 | |
Dec2022 | ₹89 Cr | -2.44 | |
Sep2022 | ₹91 Cr | -3.63 | |
Jun2022 | ₹94 Cr | 18.34 | |
Mar2022 | ₹80 Cr | - |
THEMIS MEDICARE Quarterly Operating Profit
Operating Profit | |
---|---|
Q-o-Q | -35.00 % |
Y-o-Y | -47.19 % |
Quarters | Operating Profit | % Change | |
---|---|---|---|
Dec2023 | ₹8 Cr | -35.00 | |
Sep2023 | ₹12 Cr | -42.95 | |
Jun2023 | ₹22 Cr | 107.45 | |
Mar2023 | ₹10 Cr | -31.36 | |
Dec2022 | ₹15 Cr | -28.46 | |
Sep2022 | ₹21 Cr | 4.83 | |
Jun2022 | ₹20 Cr | 41.29 | |
Mar2022 | ₹14 Cr | - |
Operating Margins | |
---|---|
Q-o-Q | -17.48 % |
Y-o-Y | -43.20 % |
Quarters | Operating Margin% | % Change | |
---|---|---|---|
Dec2023 | 9.77% | -17.48 | |
Sep2023 | 11.84% | -47.38 | |
Jun2023 | 22.5% | 72.02 | |
Mar2023 | 13.08% | -23.95 | |
Dec2022 | 17.2% | -26.65 | |
Sep2022 | 23.45% | 8.77 | |
Jun2022 | 21.56% | 19.38 | |
Mar2022 | 18.06% | - |
THEMIS MEDICARE Quarterly Profit After Tax
Profit After Tax(PAT) | |
---|---|
Q-o-Q | -71.87 % |
Y-o-Y | -83.48 % |
Quarters | Profit After Tax | % Change | |
---|---|---|---|
Dec2023 | ₹2 Cr | -71.87 | |
Sep2023 | ₹7 Cr | -43.47 | |
Jun2023 | ₹13 Cr | 107.97 | |
Mar2023 | ₹6 Cr | -50.04 | |
Dec2022 | ₹12 Cr | -10.73 | |
Sep2022 | ₹14 Cr | 16.32 | |
Jun2022 | ₹12 Cr | 54.34 | |
Mar2022 | ₹8 Cr | - |
PAT Margins | |
---|---|
Q-o-Q | -64.25 % |
Y-o-Y | -82.22 % |
Quarters | PAT Margin(%) | % Change | |
---|---|---|---|
Dec2023 | 2.42 % | -64.25 | |
Sep2023 | 6.77 % | -47.88 | |
Jun2023 | 12.99 % | 72.28 | |
Mar2023 | 7.54 % | -44.60 | |
Dec2022 | 13.61 % | -8.47 | |
Sep2022 | 14.87 % | 20.70 | |
Jun2022 | 12.32 % | 30.37 | |
Mar2022 | 9.45 % | - |
THEMIS MEDICARE Quarterly Earnings Per Share (EPS)
EPS | |
---|---|
Q-o-Q | 551.22 % |
Y-o-Y | -44.64 % |
Quarters | EPS | % Change | |
---|---|---|---|
Dec2023 | ₹8.01 | 551.22 | |
Sep2023 | ₹1.23 | -37.88 | |
Jun2023 | ₹1.98 | 117.58 | |
Mar2023 | ₹0.91 | -93.71 | |
Dec2022 | ₹14.47 | 649.74 | |
Sep2022 | ₹1.93 | 2.12 | |
Jun2022 | ₹1.89 | 75.00 | |
Mar2022 | ₹1.08 | - |
You may also like the below Video Courses
SUN PHARMACEUTICAL INDUSTRIES LTD vs CIPLA LTD vs DR REDDYS LABORATORIES LTD
ZYDUS LIFESCIENCES LTD vs DIVIS LABORATORIES LTD vs MANKIND PHARMA LTD